Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
CDX1
|
ENSG00000113722.12 | caudal type homeobox 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
CDX1 | hg19_v2_chr5_+_149546334_149546364 | -0.10 | 5.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_88427568 | 5.41 |
ENST00000393750.3
ENST00000295834.3 |
FABP1
|
fatty acid binding protein 1, liver |
chr5_-_147211226 | 4.13 |
ENST00000296695.5
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
chr20_+_56136136 | 2.75 |
ENST00000319441.4
ENST00000543666.1 |
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble) |
chr5_-_41261540 | 2.48 |
ENST00000263413.3
|
C6
|
complement component 6 |
chr1_+_159557607 | 2.02 |
ENST00000255040.2
|
APCS
|
amyloid P component, serum |
chr2_-_151344172 | 2.00 |
ENST00000375734.2
ENST00000263895.4 ENST00000454202.1 |
RND3
|
Rho family GTPase 3 |
chr7_-_16840820 | 1.98 |
ENST00000450569.1
|
AGR2
|
anterior gradient 2 |
chr11_+_114168085 | 1.95 |
ENST00000541754.1
|
NNMT
|
nicotinamide N-methyltransferase |
chr11_+_112046190 | 1.89 |
ENST00000357685.5
ENST00000393032.2 ENST00000361053.4 |
BCO2
|
beta-carotene oxygenase 2 |
chr16_+_56672571 | 1.84 |
ENST00000290705.8
|
MT1A
|
metallothionein 1A |
chr12_-_9268707 | 1.83 |
ENST00000318602.7
|
A2M
|
alpha-2-macroglobulin |
chr8_+_76452097 | 1.81 |
ENST00000396423.2
|
HNF4G
|
hepatocyte nuclear factor 4, gamma |
chr4_-_186578674 | 1.72 |
ENST00000438278.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
chr9_-_95244781 | 1.69 |
ENST00000375544.3
ENST00000375543.1 ENST00000395538.3 ENST00000450139.2 |
ASPN
|
asporin |
chr12_-_9268819 | 1.68 |
ENST00000404455.2
|
A2M
|
alpha-2-macroglobulin |
chr4_-_110723194 | 1.64 |
ENST00000394635.3
|
CFI
|
complement factor I |
chr1_+_196743912 | 1.62 |
ENST00000367425.4
|
CFHR3
|
complement factor H-related 3 |
chr3_-_196242233 | 1.62 |
ENST00000397537.2
|
SMCO1
|
single-pass membrane protein with coiled-coil domains 1 |
chr10_-_69597915 | 1.58 |
ENST00000225171.2
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
chr3_-_108672742 | 1.58 |
ENST00000261047.3
|
GUCA1C
|
guanylate cyclase activator 1C |
chr10_-_52645416 | 1.52 |
ENST00000374001.2
ENST00000373997.3 ENST00000373995.3 ENST00000282641.2 ENST00000395495.1 ENST00000414883.1 |
A1CF
|
APOBEC1 complementation factor |
chr4_-_110723335 | 1.50 |
ENST00000394634.2
|
CFI
|
complement factor I |
chr5_+_75904918 | 1.49 |
ENST00000514001.1
ENST00000396234.3 ENST00000509074.1 |
IQGAP2
|
IQ motif containing GTPase activating protein 2 |
chr18_-_68004529 | 1.48 |
ENST00000578633.1
|
RP11-484N16.1
|
RP11-484N16.1 |
chr4_+_74269956 | 1.46 |
ENST00000295897.4
ENST00000415165.2 ENST00000503124.1 ENST00000509063.1 ENST00000401494.3 |
ALB
|
albumin |
chr5_+_75904950 | 1.43 |
ENST00000502745.1
|
IQGAP2
|
IQ motif containing GTPase activating protein 2 |
chr11_+_112041253 | 1.40 |
ENST00000532612.1
|
AP002884.3
|
AP002884.3 |
chr5_-_147211190 | 1.39 |
ENST00000510027.2
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
chr7_+_80275953 | 1.37 |
ENST00000538969.1
ENST00000544133.1 ENST00000433696.2 |
CD36
|
CD36 molecule (thrombospondin receptor) |
chr4_-_186732048 | 1.35 |
ENST00000448662.2
ENST00000439049.1 ENST00000420158.1 ENST00000431808.1 ENST00000319471.9 |
SORBS2
|
sorbin and SH3 domain containing 2 |
chr4_-_16085340 | 1.35 |
ENST00000508167.1
|
PROM1
|
prominin 1 |
chr19_+_46367518 | 1.34 |
ENST00000302177.2
|
FOXA3
|
forkhead box A3 |
chr4_-_110723134 | 1.33 |
ENST00000510800.1
ENST00000512148.1 |
CFI
|
complement factor I |
chr10_-_95360983 | 1.32 |
ENST00000371464.3
|
RBP4
|
retinol binding protein 4, plasma |
chr8_-_123706338 | 1.30 |
ENST00000521608.1
|
RP11-973F15.1
|
long intergenic non-protein coding RNA 1151 |
chr4_-_16085314 | 1.30 |
ENST00000510224.1
|
PROM1
|
prominin 1 |
chrX_+_114874727 | 1.29 |
ENST00000543070.1
|
PLS3
|
plastin 3 |
chr17_-_53809473 | 1.28 |
ENST00000575734.1
|
TMEM100
|
transmembrane protein 100 |
chr1_+_57320437 | 1.26 |
ENST00000361249.3
|
C8A
|
complement component 8, alpha polypeptide |
chr10_-_69597810 | 1.26 |
ENST00000483798.2
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
chr20_-_7238861 | 1.26 |
ENST00000428954.1
|
RP11-19D2.1
|
RP11-19D2.1 |
chr3_+_149192475 | 1.25 |
ENST00000465758.1
|
TM4SF4
|
transmembrane 4 L six family member 4 |
chr8_+_67039278 | 1.24 |
ENST00000276573.7
ENST00000350034.4 |
TRIM55
|
tripartite motif containing 55 |
chrX_+_99899180 | 1.23 |
ENST00000373004.3
|
SRPX2
|
sushi-repeat containing protein, X-linked 2 |
chr4_-_186732241 | 1.23 |
ENST00000421639.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
chr16_+_82068585 | 1.23 |
ENST00000563491.1
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
chr4_-_175443943 | 1.22 |
ENST00000296522.6
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
chr1_+_196743943 | 1.21 |
ENST00000471440.2
ENST00000391985.3 |
CFHR3
|
complement factor H-related 3 |
chr3_-_168865522 | 1.17 |
ENST00000464456.1
|
MECOM
|
MDS1 and EVI1 complex locus |
chr12_-_91573249 | 1.15 |
ENST00000550099.1
ENST00000546391.1 ENST00000551354.1 |
DCN
|
decorin |
chr2_-_89161432 | 1.15 |
ENST00000390242.2
|
IGKJ1
|
immunoglobulin kappa joining 1 |
chrX_-_15619076 | 1.14 |
ENST00000252519.3
|
ACE2
|
angiotensin I converting enzyme 2 |
chr3_-_108672609 | 1.14 |
ENST00000393963.3
ENST00000471108.1 |
GUCA1C
|
guanylate cyclase activator 1C |
chr10_-_69597828 | 1.13 |
ENST00000339758.7
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
chr4_-_71532339 | 1.12 |
ENST00000254801.4
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr7_-_92855762 | 1.12 |
ENST00000453812.2
ENST00000394468.2 |
HEPACAM2
|
HEPACAM family member 2 |
chr4_-_152149033 | 1.11 |
ENST00000514152.1
|
SH3D19
|
SH3 domain containing 19 |
chr14_+_100789669 | 1.11 |
ENST00000361529.3
ENST00000557052.1 |
SLC25A47
|
solute carrier family 25, member 47 |
chr4_-_71532207 | 1.11 |
ENST00000543780.1
ENST00000391614.3 |
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr15_+_69857515 | 1.08 |
ENST00000559477.1
|
RP11-279F6.1
|
RP11-279F6.1 |
chr2_-_89521942 | 1.07 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
chr4_-_100065419 | 1.06 |
ENST00000504125.1
ENST00000505590.1 |
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide |
chr11_-_2158507 | 1.05 |
ENST00000381392.1
ENST00000381395.1 ENST00000418738.2 |
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr1_+_171283331 | 1.04 |
ENST00000367749.3
|
FMO4
|
flavin containing monooxygenase 4 |
chr14_-_67878917 | 1.04 |
ENST00000216446.4
|
PLEK2
|
pleckstrin 2 |
chr1_+_81771806 | 1.03 |
ENST00000370721.1
ENST00000370727.1 ENST00000370725.1 ENST00000370723.1 ENST00000370728.1 ENST00000370730.1 |
LPHN2
|
latrophilin 2 |
chr6_-_55740352 | 1.01 |
ENST00000370830.3
|
BMP5
|
bone morphogenetic protein 5 |
chr4_-_186733119 | 1.00 |
ENST00000419063.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
chr16_+_56685796 | 1.00 |
ENST00000334346.2
ENST00000562399.1 |
MT1B
|
metallothionein 1B |
chr17_-_56492989 | 0.99 |
ENST00000583753.1
|
RNF43
|
ring finger protein 43 |
chr2_-_165424973 | 0.99 |
ENST00000543549.1
|
GRB14
|
growth factor receptor-bound protein 14 |
chr2_-_238305397 | 0.99 |
ENST00000409809.1
|
COL6A3
|
collagen, type VI, alpha 3 |
chr10_+_85933494 | 0.99 |
ENST00000372126.3
|
C10orf99
|
chromosome 10 open reading frame 99 |
chr21_-_43735628 | 0.95 |
ENST00000291525.10
ENST00000518498.1 |
TFF3
|
trefoil factor 3 (intestinal) |
chr12_+_16500037 | 0.95 |
ENST00000536371.1
ENST00000010404.2 |
MGST1
|
microsomal glutathione S-transferase 1 |
chr2_-_163008903 | 0.93 |
ENST00000418842.2
ENST00000375497.3 |
GCG
|
glucagon |
chrX_+_110754888 | 0.93 |
ENST00000569275.1
ENST00000563467.1 |
LINC00890
|
long intergenic non-protein coding RNA 890 |
chr3_-_149095652 | 0.92 |
ENST00000305366.3
|
TM4SF1
|
transmembrane 4 L six family member 1 |
chr21_-_43735446 | 0.91 |
ENST00000398431.2
|
TFF3
|
trefoil factor 3 (intestinal) |
chrX_-_15333775 | 0.91 |
ENST00000480796.1
|
ASB11
|
ankyrin repeat and SOCS box containing 11 |
chr10_-_52645379 | 0.91 |
ENST00000395489.2
|
A1CF
|
APOBEC1 complementation factor |
chr11_+_112047087 | 0.89 |
ENST00000526088.1
ENST00000532593.1 ENST00000531169.1 |
BCO2
|
beta-carotene oxygenase 2 |
chr12_-_91573132 | 0.89 |
ENST00000550563.1
ENST00000546370.1 |
DCN
|
decorin |
chr15_+_71839566 | 0.89 |
ENST00000357769.4
|
THSD4
|
thrombospondin, type I, domain containing 4 |
chr12_+_59989918 | 0.88 |
ENST00000547379.1
ENST00000549465.1 |
SLC16A7
|
solute carrier family 16 (monocarboxylate transporter), member 7 |
chr7_+_80267949 | 0.87 |
ENST00000482059.2
|
CD36
|
CD36 molecule (thrombospondin receptor) |
chr1_+_212475148 | 0.86 |
ENST00000537030.3
|
PPP2R5A
|
protein phosphatase 2, regulatory subunit B', alpha |
chr4_+_71063641 | 0.84 |
ENST00000514097.1
|
ODAM
|
odontogenic, ameloblast asssociated |
chr6_-_138866823 | 0.84 |
ENST00000342260.5
|
NHSL1
|
NHS-like 1 |
chr3_-_148939598 | 0.80 |
ENST00000455472.3
|
CP
|
ceruloplasmin (ferroxidase) |
chr2_+_34935472 | 0.80 |
ENST00000604250.1
|
AC073218.2
|
AC073218.2 |
chr3_+_135741576 | 0.80 |
ENST00000334546.2
|
PPP2R3A
|
protein phosphatase 2, regulatory subunit B'', alpha |
chr4_-_100065440 | 0.78 |
ENST00000508393.1
ENST00000265512.7 |
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide |
chr11_+_114310164 | 0.77 |
ENST00000544196.1
ENST00000539754.1 ENST00000539275.1 |
REXO2
|
RNA exonuclease 2 |
chr12_+_20963632 | 0.77 |
ENST00000540853.1
ENST00000261196.2 |
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3 |
chr7_+_80267973 | 0.77 |
ENST00000394788.3
ENST00000447544.2 |
CD36
|
CD36 molecule (thrombospondin receptor) |
chr4_-_175205407 | 0.77 |
ENST00000393674.2
|
FBXO8
|
F-box protein 8 |
chr11_-_89224508 | 0.77 |
ENST00000525196.1
|
NOX4
|
NADPH oxidase 4 |
chr12_+_20963647 | 0.76 |
ENST00000381545.3
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3 |
chr22_+_21128167 | 0.75 |
ENST00000215727.5
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
chr4_-_22444733 | 0.75 |
ENST00000508133.1
|
GPR125
|
G protein-coupled receptor 125 |
chr3_+_119501557 | 0.74 |
ENST00000337940.4
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2 |
chr3_+_186285192 | 0.74 |
ENST00000439351.1
|
DNAJB11
|
DnaJ (Hsp40) homolog, subfamily B, member 11 |
chr1_-_935491 | 0.73 |
ENST00000304952.6
|
HES4
|
hes family bHLH transcription factor 4 |
chr3_+_190333097 | 0.73 |
ENST00000412080.1
|
IL1RAP
|
interleukin 1 receptor accessory protein |
chr1_-_68299130 | 0.73 |
ENST00000370982.3
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12 |
chr11_-_2182388 | 0.71 |
ENST00000421783.1
ENST00000397262.1 ENST00000250971.3 ENST00000381330.4 ENST00000397270.1 |
INS
INS-IGF2
|
insulin INS-IGF2 readthrough |
chr5_-_95550754 | 0.71 |
ENST00000502437.1
|
RP11-254I22.3
|
RP11-254I22.3 |
chr7_+_120629653 | 0.71 |
ENST00000450913.2
ENST00000340646.5 |
CPED1
|
cadherin-like and PC-esterase domain containing 1 |
chr11_+_107992243 | 0.70 |
ENST00000265838.4
ENST00000299355.6 |
ACAT1
|
acetyl-CoA acetyltransferase 1 |
chr15_-_45670924 | 0.68 |
ENST00000396659.3
|
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
chr8_-_42358742 | 0.68 |
ENST00000517366.1
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
chr4_+_159727272 | 0.68 |
ENST00000379346.3
|
FNIP2
|
folliculin interacting protein 2 |
chr13_-_41111323 | 0.68 |
ENST00000595486.1
|
AL133318.1
|
Uncharacterized protein |
chr13_-_33780133 | 0.68 |
ENST00000399365.3
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13 |
chr6_+_161123270 | 0.68 |
ENST00000366924.2
ENST00000308192.9 ENST00000418964.1 |
PLG
|
plasminogen |
chr12_-_371994 | 0.67 |
ENST00000343164.4
ENST00000436453.1 ENST00000445055.2 ENST00000546319.1 |
SLC6A13
|
solute carrier family 6 (neurotransmitter transporter), member 13 |
chr1_+_223101757 | 0.66 |
ENST00000284476.6
|
DISP1
|
dispatched homolog 1 (Drosophila) |
chr12_+_19389814 | 0.66 |
ENST00000536974.1
|
PLEKHA5
|
pleckstrin homology domain containing, family A member 5 |
chr4_+_159727222 | 0.65 |
ENST00000512986.1
|
FNIP2
|
folliculin interacting protein 2 |
chr14_-_53331239 | 0.65 |
ENST00000553663.1
|
FERMT2
|
fermitin family member 2 |
chr11_-_8795787 | 0.65 |
ENST00000528196.1
ENST00000533681.1 |
ST5
|
suppression of tumorigenicity 5 |
chr9_-_95186739 | 0.65 |
ENST00000375550.4
|
OMD
|
osteomodulin |
chr4_-_100065389 | 0.65 |
ENST00000512499.1
|
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide |
chr17_+_41005283 | 0.65 |
ENST00000592999.1
|
AOC3
|
amine oxidase, copper containing 3 |
chr18_+_3449695 | 0.64 |
ENST00000343820.5
|
TGIF1
|
TGFB-induced factor homeobox 1 |
chr4_+_117220016 | 0.64 |
ENST00000604093.1
|
MTRNR2L13
|
MT-RNR2-like 13 (pseudogene) |
chr2_+_89901292 | 0.64 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr3_-_96337000 | 0.63 |
ENST00000600213.2
|
MTRNR2L12
|
MT-RNR2-like 12 (pseudogene) |
chr17_-_67057114 | 0.63 |
ENST00000370732.2
|
ABCA9
|
ATP-binding cassette, sub-family A (ABC1), member 9 |
chr18_-_712544 | 0.62 |
ENST00000340116.7
ENST00000539164.1 ENST00000580982.1 |
ENOSF1
|
enolase superfamily member 1 |
chr20_+_30795664 | 0.62 |
ENST00000375749.3
ENST00000375730.3 ENST00000539210.1 |
POFUT1
|
protein O-fucosyltransferase 1 |
chr11_+_28129795 | 0.62 |
ENST00000406787.3
ENST00000342303.5 ENST00000403099.1 ENST00000407364.3 |
METTL15
|
methyltransferase like 15 |
chr18_-_712618 | 0.62 |
ENST00000583771.1
ENST00000383578.3 ENST00000251101.7 |
ENOSF1
|
enolase superfamily member 1 |
chr3_-_100712352 | 0.62 |
ENST00000471714.1
ENST00000284322.5 |
ABI3BP
|
ABI family, member 3 (NESH) binding protein |
chr22_+_25595817 | 0.61 |
ENST00000215855.2
ENST00000404334.1 |
CRYBB3
|
crystallin, beta B3 |
chr1_+_175036966 | 0.61 |
ENST00000239462.4
|
TNN
|
tenascin N |
chr1_+_196857144 | 0.60 |
ENST00000367416.2
ENST00000251424.4 ENST00000367418.2 |
CFHR4
|
complement factor H-related 4 |
chr4_+_70146217 | 0.59 |
ENST00000335568.5
ENST00000511240.1 |
UGT2B28
|
UDP glucuronosyltransferase 2 family, polypeptide B28 |
chr1_+_63073437 | 0.59 |
ENST00000593719.1
|
AL138847.1
|
CDNA FLJ26506 fis, clone KDN07105; Uncharacterized protein |
chr2_+_33359687 | 0.58 |
ENST00000402934.1
ENST00000404525.1 ENST00000407925.1 |
LTBP1
|
latent transforming growth factor beta binding protein 1 |
chr3_+_158787041 | 0.58 |
ENST00000471575.1
ENST00000476809.1 ENST00000485419.1 |
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
chr18_-_57027194 | 0.57 |
ENST00000251047.5
|
LMAN1
|
lectin, mannose-binding, 1 |
chr2_-_190448118 | 0.57 |
ENST00000440626.1
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1 |
chr14_-_23623577 | 0.56 |
ENST00000422941.2
ENST00000453702.1 |
SLC7A8
|
solute carrier family 7 (amino acid transporter light chain, L system), member 8 |
chr4_+_169418195 | 0.55 |
ENST00000261509.6
ENST00000335742.7 |
PALLD
|
palladin, cytoskeletal associated protein |
chr6_+_125304502 | 0.55 |
ENST00000519799.1
ENST00000368414.2 ENST00000359704.2 |
RNF217
|
ring finger protein 217 |
chr4_-_47983519 | 0.55 |
ENST00000358519.4
ENST00000544810.1 ENST00000402813.3 |
CNGA1
|
cyclic nucleotide gated channel alpha 1 |
chr4_+_169418255 | 0.55 |
ENST00000505667.1
ENST00000511948.1 |
PALLD
|
palladin, cytoskeletal associated protein |
chr16_+_56691606 | 0.54 |
ENST00000334350.6
|
MT1F
|
metallothionein 1F |
chr16_+_2014941 | 0.54 |
ENST00000531523.1
|
SNHG9
|
small nucleolar RNA host gene 9 (non-protein coding) |
chr11_-_89224667 | 0.54 |
ENST00000393282.2
|
NOX4
|
NADPH oxidase 4 |
chr6_-_112575912 | 0.54 |
ENST00000522006.1
ENST00000230538.7 ENST00000519932.1 |
LAMA4
|
laminin, alpha 4 |
chr12_-_9760482 | 0.54 |
ENST00000229402.3
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1 |
chr4_-_83765613 | 0.53 |
ENST00000503937.1
|
SEC31A
|
SEC31 homolog A (S. cerevisiae) |
chr5_+_138210919 | 0.53 |
ENST00000522013.1
ENST00000520260.1 ENST00000523298.1 ENST00000520865.1 ENST00000519634.1 ENST00000517533.1 ENST00000523685.1 ENST00000519768.1 ENST00000517656.1 ENST00000521683.1 ENST00000521640.1 ENST00000519116.1 |
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa |
chr2_+_33359646 | 0.53 |
ENST00000390003.4
ENST00000418533.2 |
LTBP1
|
latent transforming growth factor beta binding protein 1 |
chrX_-_45629661 | 0.53 |
ENST00000602507.1
ENST00000602461.1 |
RP6-99M1.2
|
RP6-99M1.2 |
chr12_+_19358228 | 0.52 |
ENST00000424268.1
ENST00000543806.1 |
PLEKHA5
|
pleckstrin homology domain containing, family A member 5 |
chr4_-_71532668 | 0.52 |
ENST00000510437.1
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr6_+_26087646 | 0.52 |
ENST00000309234.6
|
HFE
|
hemochromatosis |
chrX_-_131547625 | 0.51 |
ENST00000394311.2
|
MBNL3
|
muscleblind-like splicing regulator 3 |
chr10_+_114169299 | 0.51 |
ENST00000369410.3
|
ACSL5
|
acyl-CoA synthetase long-chain family member 5 |
chr15_-_67351586 | 0.51 |
ENST00000558071.1
|
RP11-798K3.2
|
RP11-798K3.2 |
chr15_-_83474806 | 0.51 |
ENST00000541889.1
ENST00000334574.8 ENST00000561368.1 |
FSD2
|
fibronectin type III and SPRY domain containing 2 |
chr12_-_111358372 | 0.51 |
ENST00000548438.1
ENST00000228841.8 |
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow |
chrX_-_131547596 | 0.51 |
ENST00000538204.1
ENST00000370849.3 |
MBNL3
|
muscleblind-like splicing regulator 3 |
chr1_+_89246647 | 0.51 |
ENST00000544045.1
|
PKN2
|
protein kinase N2 |
chr15_+_55700741 | 0.51 |
ENST00000569691.1
|
C15orf65
|
chromosome 15 open reading frame 65 |
chr3_-_100712292 | 0.50 |
ENST00000495063.1
ENST00000530539.1 |
ABI3BP
|
ABI family, member 3 (NESH) binding protein |
chrX_-_131623982 | 0.50 |
ENST00000370844.1
|
MBNL3
|
muscleblind-like splicing regulator 3 |
chr17_+_22022437 | 0.50 |
ENST00000540040.1
|
MTRNR2L1
|
MT-RNR2-like 1 |
chr1_+_169079823 | 0.49 |
ENST00000367813.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr17_-_48943706 | 0.49 |
ENST00000499247.2
|
TOB1
|
transducer of ERBB2, 1 |
chr4_-_137842536 | 0.49 |
ENST00000512039.1
|
RP11-138I17.1
|
RP11-138I17.1 |
chr13_-_114107839 | 0.49 |
ENST00000375418.3
|
ADPRHL1
|
ADP-ribosylhydrolase like 1 |
chr5_+_96079240 | 0.49 |
ENST00000515663.1
|
CAST
|
calpastatin |
chr16_-_1275257 | 0.49 |
ENST00000234798.4
|
TPSG1
|
tryptase gamma 1 |
chr2_-_89619904 | 0.47 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
chr13_+_49684445 | 0.47 |
ENST00000398316.3
|
FNDC3A
|
fibronectin type III domain containing 3A |
chr8_-_16035454 | 0.47 |
ENST00000355282.2
|
MSR1
|
macrophage scavenger receptor 1 |
chr14_+_37641012 | 0.47 |
ENST00000556667.1
|
SLC25A21-AS1
|
SLC25A21 antisense RNA 1 |
chrX_-_99987088 | 0.47 |
ENST00000372981.1
ENST00000263033.5 |
SYTL4
|
synaptotagmin-like 4 |
chr2_-_40657397 | 0.47 |
ENST00000408028.2
ENST00000332839.4 ENST00000406391.2 ENST00000542024.1 ENST00000542756.1 ENST00000405901.3 |
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1 |
chr6_-_24489842 | 0.46 |
ENST00000230036.1
|
GPLD1
|
glycosylphosphatidylinositol specific phospholipase D1 |
chrM_+_14741 | 0.46 |
ENST00000361789.2
|
MT-CYB
|
mitochondrially encoded cytochrome b |
chr11_-_89224638 | 0.46 |
ENST00000535633.1
ENST00000263317.4 |
NOX4
|
NADPH oxidase 4 |
chr1_-_156265438 | 0.46 |
ENST00000362007.1
|
C1orf85
|
chromosome 1 open reading frame 85 |
chr10_-_22292613 | 0.46 |
ENST00000376980.3
|
DNAJC1
|
DnaJ (Hsp40) homolog, subfamily C, member 1 |
chr9_+_108463234 | 0.46 |
ENST00000374688.1
|
TMEM38B
|
transmembrane protein 38B |
chr18_+_55712915 | 0.45 |
ENST00000592846.1
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr7_+_23210760 | 0.45 |
ENST00000366347.4
|
AC005082.1
|
Uncharacterized protein |
chr5_-_79946820 | 0.45 |
ENST00000604882.1
|
MTRNR2L2
|
MT-RNR2-like 2 |
chrX_-_109590174 | 0.44 |
ENST00000372054.1
|
GNG5P2
|
guanine nucleotide binding protein (G protein), gamma 5 pseudogene 2 |
chr12_-_15815626 | 0.44 |
ENST00000540613.1
|
EPS8
|
epidermal growth factor receptor pathway substrate 8 |
chr6_+_26087509 | 0.44 |
ENST00000397022.3
ENST00000353147.5 ENST00000352392.4 ENST00000349999.4 ENST00000317896.7 ENST00000357618.5 ENST00000470149.1 ENST00000336625.8 ENST00000461397.1 ENST00000488199.1 |
HFE
|
hemochromatosis |
chr4_-_185729602 | 0.44 |
ENST00000437665.3
|
ACSL1
|
acyl-CoA synthetase long-chain family member 1 |
chr17_-_46690839 | 0.43 |
ENST00000498634.2
|
HOXB8
|
homeobox B8 |
chr9_+_124103625 | 0.43 |
ENST00000594963.1
|
AL161784.1
|
Uncharacterized protein |
chr12_+_80730292 | 0.43 |
ENST00000298820.3
|
OTOGL
|
otogelin-like |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.5 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.9 | 2.8 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.9 | 5.5 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.7 | 2.8 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.5 | 2.6 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.5 | 2.5 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.5 | 1.5 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.4 | 0.7 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.3 | 1.7 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.3 | 1.0 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
0.3 | 1.0 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) response to iron ion starvation(GO:1990641) |
0.3 | 5.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.3 | 0.9 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.3 | 2.0 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.3 | 2.0 | GO:1903899 | lung goblet cell differentiation(GO:0060480) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.3 | 1.1 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.3 | 0.8 | GO:0061508 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
0.3 | 3.0 | GO:2000332 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.2 | 0.7 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
0.2 | 1.1 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.2 | 1.3 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.2 | 0.6 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.2 | 0.9 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 0.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.2 | 1.0 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.2 | 2.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 1.2 | GO:0018032 | protein amidation(GO:0018032) |
0.2 | 0.6 | GO:0060345 | spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.2 | 0.9 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.2 | 2.7 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 0.7 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.2 | 4.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.5 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.2 | 1.7 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.2 | 0.3 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.1 | 2.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 0.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.5 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.1 | 0.5 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.1 | 0.6 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 0.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.7 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 0.7 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 1.8 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.1 | 0.9 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.8 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 2.3 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.1 | 1.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.7 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 1.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 3.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 4.7 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.4 | GO:1902304 | phosphatidylserine exposure on blood platelet(GO:0097045) positive regulation of potassium ion export(GO:1902304) |
0.1 | 0.4 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 0.7 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.3 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.1 | 0.3 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
0.1 | 0.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.2 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
0.1 | 0.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.4 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.1 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.5 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.1 | 0.6 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.1 | 1.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.7 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.8 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 0.3 | GO:0070893 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
0.1 | 0.4 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.1 | 0.2 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.2 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.1 | 9.3 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 1.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 1.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.2 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 1.1 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.1 | 0.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.8 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 1.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.0 | 0.3 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.2 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.0 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 1.8 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 1.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.4 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.0 | 0.3 | GO:1902527 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) positive regulation of protein monoubiquitination(GO:1902527) |
0.0 | 1.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.0 | 0.2 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.0 | 0.4 | GO:0035799 | ureter maturation(GO:0035799) |
0.0 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.7 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 1.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.4 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.2 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.2 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.0 | 0.7 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.0 | 0.2 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.0 | 0.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.2 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.0 | 0.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 1.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 1.1 | GO:0015879 | carnitine transport(GO:0015879) |
0.0 | 0.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.2 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.5 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.4 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.0 | 0.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.1 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.0 | 0.6 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.1 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.0 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 1.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.1 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.8 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.2 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.7 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.6 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.0 | 0.1 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.0 | 0.1 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.0 | 0.1 | GO:0042262 | DNA protection(GO:0042262) |
0.0 | 0.9 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 1.0 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.0 | 0.5 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.1 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.6 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.1 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.0 | 0.5 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 0.0 | GO:2001301 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.0 | 1.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 1.3 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.2 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.1 | GO:0006775 | fat-soluble vitamin metabolic process(GO:0006775) vitamin A metabolic process(GO:0006776) |
0.0 | 0.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.5 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.5 | GO:0055001 | muscle cell development(GO:0055001) |
0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.3 | GO:0001696 | gastric acid secretion(GO:0001696) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.4 | 3.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 5.4 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 3.0 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 3.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.4 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 0.4 | GO:0036457 | keratohyalin granule(GO:0036457) |
0.1 | 1.0 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 3.2 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 2.6 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.7 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.1 | 0.2 | GO:0043614 | multi-eIF complex(GO:0043614) translation preinitiation complex(GO:0070993) glial limiting end-foot(GO:0097451) |
0.1 | 3.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.6 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.1 | 0.2 | GO:0034455 | t-UTP complex(GO:0034455) |
0.1 | 0.4 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 1.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 3.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 11.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.5 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 1.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 1.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 5.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.8 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 1.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 6.4 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.3 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.2 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 2.3 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.2 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 1.8 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.0 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.8 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 0.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 1.3 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.6 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.4 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.3 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 1.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.8 | 2.5 | GO:0019115 | benzaldehyde dehydrogenase activity(GO:0019115) |
0.8 | 5.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.5 | 3.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.5 | 2.0 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.4 | 2.7 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.4 | 1.1 | GO:0015068 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
0.3 | 1.2 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.3 | 3.0 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.3 | 1.5 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 0.7 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.2 | 0.9 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.2 | 3.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 1.2 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.2 | 2.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 1.6 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 1.2 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.2 | 0.6 | GO:0097689 | iron channel activity(GO:0097689) |
0.2 | 1.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 0.5 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.2 | 0.5 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.1 | 0.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.1 | 1.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.4 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 5.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 1.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.7 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.1 | 0.6 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 0.4 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.1 | 0.5 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.1 | 2.3 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.8 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 0.2 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
0.1 | 0.3 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.1 | 0.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.8 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 1.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 1.0 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 1.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.5 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 1.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.7 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 2.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.4 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.1 | 1.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.1 | 0.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 2.6 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 4.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 1.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 1.3 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.9 | GO:0043295 | glutathione binding(GO:0043295) |
0.0 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 6.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.7 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 1.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.5 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 1.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 1.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 1.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.2 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.0 | 1.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.2 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.0 | 4.1 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.2 | GO:0004797 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
0.0 | 0.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.0 | 0.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.2 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 1.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 2.8 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.8 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 2.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
0.0 | 0.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 1.4 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.1 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.0 | 0.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 1.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 1.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 1.6 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.3 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 3.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 2.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.3 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 5.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 1.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 1.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 7.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 5.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 2.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 3.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 1.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 3.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 8.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 1.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 3.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 1.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 1.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 2.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 1.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 1.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 1.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 1.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 3.0 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |